CSS LLC’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

CSS LLC’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,359	Closed	-$168K	–	990
2023 Q4	$168K	Sell	55,359 -1,695	-3%	-$5.14K	0.01%	651
2023 Q3	$162K	Sell	57,054 -3,400	-6%	-$9.37K	0.01%	634
2023 Q2	$157K	Buy	+60,454	New	+$127K	0.01%	691

Other funds holding CYT

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFO

Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

CSS LLC's CYT Position: Q1 2024 in Review

CSS LLC sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 55,359 shares — an estimated $168K sold.

CSS LLC first reported a position in CYT in Q2 2023 and held it in 3 quarters. The position peaked at $168K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

CSS LLC reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
CSS LLC sold 55,359 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $168K.
CSS LLC first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
CSS LLC's Cyteir Therapeutics, Inc. Common Stock position peaked at $168K in Q4 2023.
4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on CSS LLC's 13F filing for Q1 2024, filed 15 May 2024.